← back to search

André Hennigs

Heidelberg University · DE
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Breast Implant and Reconstruction, and Ultrasound Imaging and Elastography.
h-index
23
citations
2,413
works
163
NIH funding
primary concept
email

Recent publications

Incidence and Risk Assessment of Capsular Contracture in Breast Cancer Patients following Post-Mastectomy Radiotherapy and Implant-Based Reconstruction
Cancers 2024cited by 21position: middledoi
Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III Trial
International Journal of Radiation Oncology*Biology*Physics 2023cited by 9position: middledoi
The importance of multi-modal imaging and clinical information for humans and AI-based algorithms to classify breast masses (INSPiRED 003): an international, multicenter analysis
European Radiology 2022cited by 29position: middledoi
Intelligent multi-modal shear wave elastography to reduce unnecessary biopsies in breast cancer diagnosis (INSPiRED 002): a retrospective, international, multicentre analysis
European Journal of Cancer 2022cited by 24position: middledoi
Methods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients’ and Physicians’ Assessment from the Randomized IMRT-MC2 Trial
Cancers 2022cited by 4position: middledoi
Intraoperative Gewinnung von Frischgewebsproben für molekulargenetische Analysen zwecks individualisierter postneoadjuvanter Therapie
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2021cited by 0position: middledoi
Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)
Radiation Oncology 2020cited by 11position: middledoi
Wie hat sich die Anwendung von adjuvanter zu neoadjuvanter Chemotherapie beim frühen Mammakarzinom verändert? – Daten von 104 deutschen Brustzentren 2008-2017
Geburtshilfe und Frauenheilkunde 2020cited by 0position: lastdoi
Receptor discordance between primary tumor and metastasis influences CTC-status
Geburtshilfe und Frauenheilkunde 2020cited by 0position: middledoi
Refining scores based on patient reported outcomes – statistical and medical perspectives
BMC Medical Research Methodology 2019cited by 63position: middledoi
Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score
Breast Cancer Research and Treatment 2019cited by 11position: middledoi
RESPONDER – diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial
BMC Cancer 2018cited by 54position: middledoi
Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis
European Radiology 2018cited by 22position: middledoi
Development and psychometric validation of a shorter version of the Breast Cancer Treatment Outcome Scale (BCTOS-12)
The Breast 2018cited by 15position: firstdoi
Veränderungen in der Anwendung und beim Outcome von Chemotherapie beim frühen Mammakarzinom in der letzten Dekade (2003 – 2014)
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2017cited by 0position: middledoi
Klaus-Dieter-Schulz-Versorgungsforschungspreis - Veränderungen in der Anwendung und beim Outcome von Chemotherapie beim frühen Mammakarzinom in der letzten Dekade (2003–2014)
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2017cited by 0position: middledoi
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study
BMC Cancer 2016cited by 198position: firstdoi
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
Breast Cancer Research and Treatment 2016cited by 63position: firstdoi
Abstract P1-07-12: Prognosis of clinico-pathological breast cancer subtypes in routine clinical care
Cancer Research 2016cited by 0position: firstdoi
Ergebnisqualität von Brustkrebs-Subtypen in der klinischen Routine – eine große, prospektive Kohortenstudie
Geburtshilfe und Frauenheilkunde 2016cited by 0position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Golatta · University Medical Center Hamburg-Eppendorf16 papers (2016–2024)Jörg Heil · Breast Center11 papers (2016–2023)Andreas Schneeweiß · NSABP Foundation10 papers (2016–2021)Fabian Riedel · Heidelberg University9 papers (2016–2020)Florian Schütz · Park-Klinik Weißensee7 papers (2016–2019)Hans‐Peter Sinn · Heidelberg University7 papers (2016–2020)Jürgen Debus · NYU Langone Health6 papers (2016–2024)Frederik Marmé · Hospital Universitario Virgen del Rocío6 papers (2016–2019)Ádám Gondos · Roche (Switzerland)6 papers (2016–2017)Christof Sohn · University Hospital Heidelberg5 papers (2016–2020)Joerg Heil · University of Lübeck5 papers (2016–2018)Geraldine Rauch · Charité - Universitätsmedizin Berlin4 papers (2018–2019)Laila König · Heidelberg University4 papers (2020–2024)Katharina Smetanay · Heidelberg University4 papers (2016–2019)Juliane Hörner‐Rieber · German Cancer Research Center4 papers (2020–2024)Tobias Förster · Ludwig-Maximilians-Universität München4 papers (2020–2024)Katja Lindel · University Hospital Heidelberg4 papers (2016–2017)Markus Wallwiener · German Society of Surgery3 papers (2020–2023)David Krug · University Hospital Heidelberg3 papers (2020–2023)Nathalie Arians · Heidelberg University3 papers (2022–2024)